A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation

Stoughton, 1979, Topical antibiotic for acne vulgaris, Arch Dermatol, 115, 486, 10.1001/archderm.1979.04010040064019 1975, Systemic antibiotics for treatment of acne vulgaris: efficacy and safety—Ad Hoc Committee Report of National Programme for Dermatology, Arch Dermatol, 11, 1630 Mills, 1975, The clinical effectiveness of topical erythromycin in acne vulgaris, Cutis, 15, 93 Stoughton, 1980, Double blind comparison of topical 1 % clindamycin phosphate and oral tetracycline in the treatment of acne vulgaris, Cutis, 26, 424 Decker, 1981, Topical clindamycin therapy for acne vulgaris, Arch Dermatol, 117, 482, 10.1001/archderm.1981.01650080036024 Thomas, 1982, Comparison of topical erythromycin 1.5% solution versus topical clindamycin phosphate 1.0%, Cutis, 29, 624 Shalita, 1984, Topical erythromycin versus clindamycin therapy for acne, Arch Dermatol, 120, 351, 10.1001/archderm.1984.01650390073015 Braathen, 1984, Topical clindamycin versus oral tetracycline and placebo in acne vulgaris, Scand J Infect Dis, 43, 71 Feucht, 1980, Topical erythromycin with zinc and acne, J Am Acad Dermatol, 3, 483, 10.1016/S0190-9622(80)80114-9 Strauss, 1984, Acne treatment with topical erythromycin and zinc: effect on Propionbacterium acnes and free fatty acid composition, J Am Acad Dermatol, 11, 86, 10.1016/S0190-9622(84)70139-3